Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. trades as GLUE and has a market capitalization of $2.07 B, making it the #2115 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $123.67M, up 63.5% from the prior year and net income of -$38.60M. This page tracks Monte Rosa Therapeutics, Inc. through 352 SEC filings, with financial statements and metrics updated as new reports are filed.